#gemcabene

Top Pharma News of the Week – August 13th

All The Most Important Pharmaceutical News Stories Of The Week – August 2018 – Week # 2 FDA Approves ORKAMBI® (lumacaftor/ivacaftor) as First Medicine to Treat the Underlying Cause of Cystic Fibrosis for Children Ages 2-5 Years with Most Common Form of the Disease

August 7, 2018

Vertex Pharmaceuticals Incorporated has announced the U.S. Food and Drug Administration (FDA) has approved…